China targets Germany's Bayer in drug price investigation: firm
AFPSHANGHAI--Chinese authorities have visited an office of German pharmaceutical giant Bayer, the company said Friday, making it the latest target in a probe of foreign drug firms over high prices.
September 14, 2013, 12:01 am TWN
One of its offices was visited at the end of last month to investigate a potential case of “unfair competition,” Bayer HealthCare said in a statement to AFP.
China is mounting a sweeping probe into foreign pharmaceutical firms, accusing some of abusing their monopoly positions to boost prices unfairly. Bayer said it was visited by officials of a local branch of the State Administration for Industry & Commerce, which handles market supervision and regulation.
It did not identify the location.